COVID-19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice. Sriwijitalai W, Wiwanitkit V. Clin Exp Dermatol 2022 Mar 31. doi: 10.1111/ced.15202.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sriwijitalai W, Wiwanitkit V. COVID-19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice. Clin Exp Dermatol 2022 Mar 31. doi: 10.1111/ced.15202.
PMID: 35357031